IFNG and osteoporosis: The therapeutic potential of IFN-γ in osteoporosis is modulated by various factors, including but not limited to the specific dosage, frequency, administration route, and duration of treatment, highlighting the importance of carefully considering these variables in designing IFN-γ-based therapeutic strategies.